Kardiologie - Was ist neu?

Literatur

• 1 Ardissino D, Cavallini C, Bramucci E, Indolfi C, Marzocchi A, Manari A, Angeloni G, Carosio G, Bonizzoni E, Colusso S, Repetto M, Merlini P A. Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial.  Jama. 2004;  292 2727-2734
• 2 Bardy G H, Lee K L, Mark D B, Poole J E, Packer D L, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty S E, Clapp-Channing N, Davidson-Ray L D, Fraulo E S, Fishbein D P, Luceri R M, Ip J H. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.  N Engl J Med. 2005;  352 225-237
• 3 Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B, Menard J, Mallion J M. Cardiovascular prognosis of „masked hypertension” detected by blood pressure self-measurement in elderly treated hypertensive patients.  Jama. 2004;  291 1342-1349
• 4 Braunwald E, Domanski M J, Fowler S E, Geller N L, Gersh B J, Hsia J, Pfeffer M A, Rice M M, Rosenberg Y D, Rouleau J L. Angiotensin-converting-enzyme inhibition in stable coronary artery disease.  N Engl J Med. 2004;  351 2058-2068
• 5 Bristow M R, Saxon L A, Boehmer J, Krueger S, Kass D A, De Marco T, Carson P, DiCarlo L, DeMets D, White B G, DeVries D W, Feldman A M. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.  N Engl J Med. 2004;  350 2140-2150
• 6 Cleland J G, Daubert J C, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L. The effect of cardiac resynchronization on morbidity and mortality in heart failure.  N Engl J Med. 2005;  352 1539-49
• 7 Colhoun H M, Betteridge D J, Durrington P N, Hitman G A, Neil H A, Livingstone S J, Thomason M J, Mackness M I, Charlton-Menys V, Fuller J H. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.  Lancet. 2004;  364 685-696
• 8 Grundy S M, Cleeman J I, Merz C N, Brewer H B, Clark L T, Hunninghake D B, Pasternak R C, Smith S C, Stone N J. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.  Circulation. 2004;  110 227-239
• 9 Hohnloser S H, Kuck K H, Dorian P, Roberts R S, Hampton J R, Hatala R, Fain E, Gent M, Connolly S J. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction.  N Engl J Med. 2004;  351 2481-2488
• 10 LaRosa J C, Grundy S M, Waters D D, Shear C, Barter P, Fruchart J C, Gotto A M, Greten H, Kastelein J J, Shepherd J, Wenger N K. Intensive lipid lowering with atorvastatin in patients with stable coronary disease.  N Engl J Med. 2005;  352 1425-1435
• 11 Lonn E, Bosch J, Yusuf S, Sheridan P, Pogue J, Arnold J M, Ross C, Arnold A, Sleight P, Probstfield J, Dagenais G R. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.  Jama. 2005;  293 1338-1347
• 12 Nissen S E, Tuzcu E M, Schoenhagen P, Brown B G, Ganz P, Vogel R A, Crowe T, Howard G, Cooper C J, Brodie B, Grines C L, DeMaria A N. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.  Jama. 2004;  291 1071-1080
• 13 Wollert K C, Meyer G P, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, Fichtner S, Korte T, Hornig B, Messinger D, Arseniev L, Hertenstein B, Ganser A, Drexler H. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial.  Lancet. 2004;  364 141-148